Sarepta Therapeutics Inc (SRPT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sarepta Therapeutics Inc   (NASDAQ: SRPT)


Sarepta Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sarepta Therapeutics Inc's ROI in the second quarter of 2026?
Sarepta Therapeutics Inc recorded a cumulative net loss of $-137 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -5.29%.

Within the Healthcare sector 208 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1194 to 2122.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -15.52 % -7.78 % -4.47 % 5.9 % 15.26 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2,686 2,796 2,698 2,163 3,203
Return On Investment (TTM) -5.29 % 2.4 % -26.01 % -4.94 % -1.89 %
SRPT's Overall Ranking # 2122 # 1194 # 2488 # 2855 # 2194
Seq. Investment Change TTM -4.76 % -1.02 % -4.64 % -6.03 % 3.97 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -137 65 -713 -142 -58

SRPT Company Profile >> Back to SRPT Roi Comparisons >> See Annual SRPT Return On Investment



Return On Investment SRPT's Ranking
Within: No.
Industry # 71
Sector # 209
Overall # 2122

Return On Investment Statistics
High Average Low
7.76 %
-54.81 %
-330.67 %
(Dec 31 2024)   (Sep 30 2012)



  News about Sarepta Therapeutics Inc Return on Investment ROI

Transforming Lives Sarepta Therapeutics Set to Unveil Groundbreaking Data at WMS 2024 Congress,

September 26, 2024

In the rapidly evolving landscape of genetic medicine, Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a frontrunner in precision therapies for rare diseases, is set to make significant waves at the upcoming 29th Annual Congress of the World Muscle Society 2024 (WMS 2024) in Prague, Czechia. Taking place from October 8-12, 2024, this congress represents a pivotal platform for sharing groundbreaking research and ushering in transformative therapies for neuromuscular disorders.Sarepta is poised to unveil compelling new data from its delandistrogene moxeparvovec clinical development program, which promises to offer hope and improved outcomes for patients afflicted by Duchenne muscular dystrophy (DMD). Among the studies featured will be results from Studies 9001-101, 9001-103 (ENDEAVOR), and additional investigations that explore the safety and efficacy of this innovative genetic medicine.





Financial Statements
Sarepta Therapeutics Inc's II. Quarter Investments $ 2,686 Millions SRPT's Balance sheet
Sarepta Therapeutics Inc's II. Quarter Income $ -5 Millions Quarterly SRPT's Income Statement
SRPT's Income by Division See SRPT's Income by Division


SRPT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,254 3,231 2,611 2,509 2,695
Y / Y Investment Growth -30.24 % 23.77 % 4.07 % -6.92 % 51.33 %
Net Income in Millions -713 235 -536 -703 -419
Y / Y Net Income Growth - - - - -
Annual Return On Investment -31.65 % 7.28 % -20.53 % -28.04 % -15.54 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SRPT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SRPT's Competitors
Subscribers only: Roi for Sarepta Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for SRPT's Customers

Other Ratios
SRPT's Roa SRPT's Inventory Turnover Ratio SRPT's Growth Rates SRPT's Dividend Statistics
SRPT's Profitability Ratios SRPT's Asset Turnover Ratio SRPT's Dividend Growth
SRPT's Roe SRPT's Valuation Ratios SRPT's Financial Strength Ratios SRPT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-11T09:41:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.